Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :523
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


A Phase 3, randomized, double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting: Results of an Indian population subanalysis

Maru A, Gangadharan V P, Desai C J, Mohapatra R K, Carides A D

Year : 2013| Volume: 50| Issue : 4 | Page no: 285-291

   This article has been cited by
1 Fosaprepitant Dimeglumine: A Review in the Prevention of Nausea and Vomiting Associated with Chemotherapy
Karly P. Garnock-Jones
Drugs. 2016; 76(14): 1365
[Pubmed]  [Google Scholar] [DOI]
2 Role of rolapitant in chemotherapy-induced emesis
Ian Olver
The Lancet Oncology. 2015; 16(9): 1006
[Pubmed]  [Google Scholar] [DOI]
3 Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries
Ruey Kuen Hsieh,Alexandre Chan,Hoon-Kyo Kim,Shiying Yu,Jong Gwang Kim,Myung-Ah Lee,Johan Dalén,Hun Jung,Yan Ping Liu,Thomas A. Burke,Dorothy M. K. Keefe
Supportive Care in Cancer. 2015; 23(1): 263
[Pubmed]  [Google Scholar] [DOI]
4 Anticipatory nausea in animal models: a review of potential novel therapeutic treatments
Erin M. Rock,Cheryl L. Limebeer,Linda A. Parker
Experimental Brain Research. 2014;
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow